Close this search box.

Exploring Multiple Strategic Options: A Multi-Track Process

David Chacko, Erasca

“The RNA team is responsive and efficient and understands the nuances of valuation as pertains to our sector, and we valued our partnership with them.”

Chris Vasquez, Biodesix

“The RNA team has been incredibly professional, very responsive to our on-going and sometimes tight turnaround valuation requests and has been an absolute pleasure to work with.”

Marshall Fordyce, Vera Therapeutics

“The RNA team helped us from inception through our IPO and beyond. They are one of the top firms that I know of at the intersection of valuation, biotech and finance. I’d recommend them for my life science venture-backed company colleagues.”

Sign Up for Periodic Updates

Enter your email address below to receive updates from RNA Advisors.